EGLN3 and cancer: Notably, deletion of the PHD3 domain in MLL1 results in leukemia and cell line immortalization [21–23], and insertion of PHD3 even within oncogenic MLL1 protein fusions restores Cyp33 mediated repression of genes involved in cancer cell immortalization [23].